<!DOCTYPE html>



<html lang="en">



	<meta charset="UTF-8">

	<meta name="viewport" content="width=device-width, initial-scale=1.0">

	<style>


    .node {

        stroke: #fff;

        stroke-width: 2px;

    }

    

    .link {

        stroke: #777;

        stroke-width: 2px;

    }



</style>

<body>

<a href="https://riskrunners.com">Home</a><br>




<a href="#risk_factors">Jump to Risk Factors</a><br>



<a href="#industry">Jump to Industries</a><br>


<a href="#exposure">Jump to Exposures</a><br>


<a href="#event_code">Jump to Event Codes</a><br>


<a href="#wiki">Jump to Wiki Summary</a><br><br>


    <script src="https://d3js.org/d3.v3.min.js"></script>

    <script>


// set a width and height for our SVG

var width = 3000,


    height = 3000;

    
// setup links

var links =     [
{source: "START_HERE", target: "9: certain risks", fill: "#dda0dd"},
{source: "9: certain risks", target: "11: others risks", fill: "#1a1110"},
{source: "11: others risks", target: "11: uncertainties", fill: "#1a1110"},
{source: "11: uncertainties", target: "11: financial condition performance development", fill: "#1a1110"},
{source: "11: financial condition performance development", target: "11: operations", fill: "#1a1110"},
{source: "11: operations", target: "11: government regulation which could limit", fill: "#1a1110"},
{source: "11: others risks", target: "13: primary regulatory bodies", fill: "#009f6b"},
{source: "13: primary regulatory bodies", target: "13: regulatory", fill: "#009f6b"},
{source: "13: regulatory", target: "13: United States ", fill: "#009f6b"},
{source: "13: United States ", target: "13: FDA and FTC Failure ", fill: "#009f6b"},
{source: "13: FDA and FTC Failure ", target: "13: requirements", fill: "#009f6b"},
{source: "13: primary regulatory bodies", target: "18: Approvals ", fill: "#f4a460"},
{source: "18: Approvals ", target: "18: conditioned", fill: "#f4a460"},
{source: "18: conditioned", target: "18: reformulation", fill: "#f4a460"},
{source: "18: reformulation", target: "18: ingredients", fill: "#f4a460"},
{source: "18: Approvals ", target: "22: product liability", fill: "#c2b280"},
{source: "22: product liability", target: "22: litigation", fill: "#c2b280"},
{source: "22: litigation", target: "22: prosecute such", fill: "#c2b280"},
{source: "22: prosecute such", target: "22: product liability insurance which", fill: "#c2b280"},
{source: "22: product liability insurance which", target: "22: insurance coverage will", fill: "#c2b280"},
{source: "22: insurance coverage will", target: "22: adequate insurance coverage", fill: "#c2b280"},
{source: "22: product liability", target: "52: Adverse ", fill: "#26619c"},
{source: "52: Adverse ", target: "52: publicity may", fill: "#26619c"},
{source: "52: publicity may", target: "52: financial condition", fill: "#26619c"},
{source: "52: financial condition", target: "52: operations", fill: "#26619c"},
{source: "52: Adverse ", target: "63: property rights", fill: "#9ab973"},
{source: "63: property rights", target: "63: intellectual property rights", fill: "#9ab973"},
{source: "63: intellectual property rights", target: "63: others there", fill: "#9ab973"},
{source: "63: others there", target: "63: parties will", fill: "#9ab973"},
{source: "63: parties will", target: "63: intellectual property infringement", fill: "#9ab973"},
{source: "63: intellectual property infringement", target: "63: management", fill: "#9ab973"},
{source: "63: property rights", target: "START_HERE", fill: "#9ab973"}]; 
    // create empty nodes array
    var nodes = {};
	var colorFill = [];
	
    // compute nodes from links data
    links.forEach(function(link) {
        link.source = nodes[link.source] ||
            (nodes[link.source] = {name: link.source});
        link.target = nodes[link.target] ||
            (nodes[link.target] = {name: link.target});
		colorFill.push({name: link.source.name, fill: link.fill });
		colorFill.push({name: link.target.name, fill: link.fill });
    });
	
	console.log(colorFill);


    // add a SVG to the body for our viz
    var svg=d3.select('body').append('svg')
        .attr("viewBox", "0 0 " + width + " " + height );

    // use the force
    var force = d3.layout.force()
		.charge(-5000)
		.gravity(0.3)
        .size([width, height])
        .nodes(d3.values(nodes))
        .links(links)
        .on("tick", tick)
        .linkDistance(200)
        .start();

    // add links
    var link = svg.selectAll('.link')
        .data(links)
        .enter().append('line')
        .attr('class', 'link'); 

    // add nodes
    var node = svg.selectAll('.node')
        .data(force.nodes())
        .enter().append('circle')
        .attr('class', 'node')
        .attr('r', width * 0.0035)
		.style("fill", function(d) {
									for (var i = 0; i < colorFill.length; i++) {
										//console.log(d.name);
										if(colorFill[i].name == d.name){
											console.log(colorFill[i].fill);
											return colorFill[i].fill;
										}
									} return "#555";
									
									});
	var label = svg.selectAll(null)
		.data(force.nodes())
		.enter()
		.append("text")
		.text(function (d) { return d.name; })
		.style("text-anchor", "middle")
		.style("fill", "#555")
		.style("font-family", "Arial")
		.style("font-size", 34);


    // what to do 
    function tick(e) {
        
        node.attr('cx', function(d) { return d.x = Math.max(6, Math.min(width - 6, d.x)); })
            .attr('cy', function(d) { return d.y = Math.max(6, Math.min(height - 6, d.y)); })
            .call(force.drag);
            
        link.attr('x1', function(d) { return d.source.x; })
            .attr('y1', function(d) { return d.source.y; })
            .attr('x2', function(d) { return d.target.x; })
            .attr('y2', function(d) { return d.target.y; });
		
		label.attr("x", function(d){ return d.x; })
             .attr("y", function (d) {return d.y - 10; });
        
    }
    
</script><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='industry'>Industries</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Automobile Manufacturers</td>
    </tr>
    <tr>
      <td>Motorcycle Manufacturers</td>
    </tr>
    <tr>
      <td>Health Care Distribution and Services</td>
    </tr>
    <tr>
      <td>Asset Management and Custody Banks</td>
    </tr>
    <tr>
      <td>Technology Hardware Storage and Peripherals</td>
    </tr>
    <tr>
      <td>Information Technology</td>
    </tr>
    <tr>
      <td>Technology Hardware and Equipment</td>
    </tr>
    <tr>
      <td>Health Care Facilities</td>
    </tr>
    <tr>
      <td>Home Improvement Retail</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='exposure'>Exposures</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Military</td>
    </tr>
    <tr>
      <td>Rights</td>
    </tr>
    <tr>
      <td>Regime</td>
    </tr>
    <tr>
      <td>Judicial</td>
    </tr>
    <tr>
      <td>Express intent</td>
    </tr>
    <tr>
      <td>Provide</td>
    </tr>
    <tr>
      <td>Intelligence</td>
    </tr>
    <tr>
      <td>Crime</td>
    </tr>
    <tr>
      <td>Ease</td>
    </tr>
    <tr>
      <td>Leadership</td>
    </tr>
    <tr>
      <td>Political reform</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='event_code'>Event Codes</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Solicit support</td>
    </tr>
    <tr>
      <td>Force</td>
    </tr>
    <tr>
      <td>Sanction</td>
    </tr>
    <tr>
      <td>Sports contest</td>
    </tr>
    <tr>
      <td>Veto</td>
    </tr>
    <tr>
      <td>Accident</td>
    </tr>
    <tr>
      <td>Yield to order</td>
    </tr>
    <tr>
      <td>Release or return</td>
    </tr>
    <tr>
      <td>Host meeting</td>
    </tr>
    <tr>
      <td>Psychological state</td>
    </tr>
    <tr>
      <td>Grant</td>
    </tr>
    <tr>
      <td>Agree</td>
    </tr>
    <tr>
      <td>Riot</td>
    </tr>
    <tr>
      <td>Yield</td>
    </tr>
    <tr>
      <td>Natural disaster</td>
    </tr>
    <tr>
      <td>Adjust</td>
    </tr>
    <tr>
      <td>Warn</td>
    </tr>
    <tr>
      <td>Acknowledge responsibility</td>
    </tr>
    <tr>
      <td>Human death</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='wiki'>Wiki</th>
      <th>Wiki Summary</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Risk_management">Risk management</a></td>
      <td>Risk management is the identification, evaluation, and prioritization of risks (defined in ISO 31000 as the effect of uncertainty on objectives) followed by coordinated and economical application of resources to minimize, monitor, and control the probability or impact of unfortunate events or to maximize the realization of opportunities.\nRisks can come from various sources including uncertainty in international markets, threats from project failures (at any phase in design, development, production, or sustaining of life-cycles), legal liabilities, credit risk, accidents, natural causes and disasters, deliberate attack from an adversary, or events of uncertain or unpredictable root-cause.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Financial_ratio">Financial ratio</a></td>
      <td>A financial ratio or accounting ratio is a relative magnitude of two selected numerical values taken from an enterprise's financial statements. Often used in accounting, there are many standard ratios used to try to evaluate the overall financial condition of a corporation or other organization.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Financial_law">Financial law</a></td>
      <td>Financial law is the law and regulation of the insurance, derivatives, commercial banking, capital markets and investment management sectors. Understanding Financial law is crucial to appreciating the creation and formation of banking and financial regulation, as well as the legal framework for finance generally.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Arithmetic">Arithmetic</a></td>
      <td>Arithmetic (from Ancient Greek  ἀριθμός (arithmós) 'number', and  τική [τέχνη] (tikḗ [tékhnē]) 'art, craft') is an elementary part of mathematics that consists of the study of the properties of the traditional operations on numbers—addition, subtraction, multiplication, division, exponentiation, and extraction of roots. In the 19th century, Italian mathematician Giuseppe Peano formalized arithmetic with his Peano axioms, which are highly important to the field of mathematical logic today.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operation_Mincemeat">Operation Mincemeat</a></td>
      <td>Operation Mincemeat was a successful British deception operation of the Second World War to disguise the 1943 Allied invasion of Sicily. Two members of British intelligence obtained the body of Glyndwr Michael, a tramp who died from eating rat poison, dressed him as an officer of the Royal Marines and placed personal items on him identifying him as the fictitious Captain (Acting Major) William Martin.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Special_Activities_Center">Special Activities Center</a></td>
      <td>The Special Activities Center (SAC) is a division of the Central Intelligence Agency responsible for covert operations and paramilitary operations. The unit was named Special Activities Division (SAD) prior to 2015.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operations_research">Operations research</a></td>
      <td>Operations research (British English: operational research), often shortened to the initialism OR, is a discipline that deals with the development and application of advanced analytical methods to improve decision-making. It is sometimes considered to be a subfield of mathematical sciences.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Surgery">Surgery</a></td>
      <td>Surgery is a medical or dental specialty that uses operative manual and instrumental techniques on a person to investigate or treat a pathological condition such as a disease or injury, to help improve bodily function, appearance, or to repair unwanted ruptured areas.\nThe act of performing surgery may be called a surgical procedure, operation, or simply "surgery".</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Bitwise_operation">Bitwise operation</a></td>
      <td>In computer programming, a bitwise operation operates on a bit string, a bit array or a binary numeral (considered as a bit string) at the level of its individual bits. It is a fast and simple action, basic to the higher-level arithmetic operations and directly supported by the processor.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Requirement">Requirement</a></td>
      <td>In product development and process optimization, a requirement is a singular documented physical or functional need that a particular design, product or process aims to satisfy. It is commonly used in a formal sense in engineering design, including for example in systems engineering, software engineering, or enterprise engineering.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Non-functional_requirement">Non-functional requirement</a></td>
      <td>In systems engineering and requirements engineering, a non-functional requirement (NFR) is a requirement that specifies criteria that can be used to judge the operation of a system, rather than specific behaviours. They are contrasted with functional requirements that define specific behavior or functions.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Requirements_engineering">Requirements engineering</a></td>
      <td>Requirements engineering (RE) is the process of defining, documenting, and maintaining requirements in the engineering design process. It is a common role in systems engineering and software engineering.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Requirements_analysis">Requirements analysis</a></td>
      <td>In systems engineering and software engineering, requirements analysis focuses on the tasks that determine the needs or conditions to meet the new or altered product or project, taking account of the possibly conflicting requirements of the various stakeholders, analyzing, documenting, validating and managing software or system requirements.Requirements analysis is critical to the success or failure of a systems or software project. The requirements should be documented, actionable, measurable, testable, traceable, related to identified business needs or opportunities, and defined to a level of detail sufficient for system design.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Age_of_candidacy">Age of candidacy</a></td>
      <td>Age of candidacy is the minimum age at which a person can legally hold certain elected government offices. In many cases, it also determines the age at which a person may be eligible to stand for an election or be granted ballot access.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Market_requirements_document">Market requirements document</a></td>
      <td>A market requirements document (MRD) in project management and systems engineering, is a document that expresses the customer's wants and needs for the product or service.\nIt is typically written as a part of product marketing or product management.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Visa_requirements_for_British_citizens">Visa requirements for British citizens</a></td>
      <td>Visa requirements for British citizens are administrative entry restrictions by the authorities of other states placed on citizens of the United Kingdom. As of 30 April 2022, British citizens had visa-free or visa on arrival access to 187 countries and territories, ranking their passport 5th in terms of travel freedom (tied with France, Ireland and Portugal) according to the Henley Passport Index.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Requirements_elicitation">Requirements elicitation</a></td>
      <td>In requirements engineering, requirements elicitation is the practice of researching and discovering the requirements of a system from users, customers, and other stakeholders. The practice is also sometimes referred to as "requirement gathering".</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Business_requirements">Business requirements</a></td>
      <td>Business requirements, also known as stakeholder requirements specifications (StRS), describe the characteristics of a proposed system from the viewpoint of the system's end user like a CONOPS. Products, systems, software, and processes are ways of how to deliver, satisfy, or meet business requirements.  Consequently, business requirements are often discussed in the context of developing or procuring software or other systems.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Ingredient">Ingredient</a></td>
      <td>An ingredient is a substance that forms part of a mixture (in a general sense). For example, in cooking, recipes specify which ingredients are used to prepare a specific dish.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Active_ingredient">Active ingredient</a></td>
      <td>An active ingredient is the ingredient in a pharmaceutical drug or pesticide that is biologically active. The similar terms active pharmaceutical ingredient (also abbreviated as API) and bulk active are also used in medicine, and the term active substance may be used for natural products.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Excipient">Excipient</a></td>
      <td>An excipient is a substance formulated alongside the active ingredient of a medication, included for the purpose of long-term stabilization, bulking up solid formulations that contain potent active ingredients in small amounts (thus often referred to as "bulking agents", "fillers", or "diluents"), or to confer a therapeutic enhancement on the active ingredient in the final dosage form, such as facilitating drug absorption, reducing viscosity, or enhancing solubility. Excipients can also be useful in the manufacturing process, to aid in the handling of the active substance concerns such as by facilitating powder flowability or non-stick properties, in addition to aiding in vitro stability such as prevention of denaturation or aggregation over the expected shelf life.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/The_Main_Ingredient">The Main Ingredient</a></td>
      <td>The Main Ingredient was an American soul and R&amp;B group best known for their 1972 hit song "Everybody Plays the Fool".\n\n\n== Early history ==\nThe group was formed in Harlem, New York City in 1964 as a trio called the Poets, composed of lead singer Donald McPherson (July 9, 1941 – July 3, 1971), Luther Simmons, Jr.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Sushi">Sushi</a></td>
      <td>Su Shi (traditional Chinese: 蘇軾; simplified Chinese: 苏轼; 8 January 1037 – 24 August 1101), courtesy name Zizhan (Chinese: 子瞻), art name Dongpo (Chinese: 東坡), was a Chinese scholar-official, active as a poet, essayist, calligrapher and painter during the Song dynasty. A major personality of the Song era, at times holding high-level political positions, Su was also an important figure in Song Dynasty politics, aligning himself with Sima Guang and others, against the New Policy party led by Wang Anshi, gaining some level of popular support through his actions, and also sometimes experiencing politically motivated reversals to his government career.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Ingredients_(film)">Ingredients (film)</a></td>
      <td>Ingredients: The Local Food Movement Takes Root is a 2009 documentary film about the shortcomings of America's industrialized food system against a rising local food movement, whose proponents are shrinking the gap between farmland and dinner table. The film is directed by Robert Bates, produced by Brian Kimmel (The Kitchen Sessions with Charlie Trotter) and narrated by actress Bebe Neuwirth.Chefs Alice Waters, Peter Hoffman, Kathy Whims, and Greg Higgins share their views as growers, restaurateurs, and consumers around the country, from Willamette Valley, Oregon to the urban food desert Harlem, New York, discuss their methods for bringing food production back home.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Secret_ingredient">Secret ingredient</a></td>
      <td>A secret ingredient is a component of a product that is closely guarded from public disclosure for competitive advantage.  Sometimes the ingredient makes a noticeable difference in the way a product performs, looks  or tastes; other times it is used for advertising puffery.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Ingredients_of_cosmetics">Ingredients of cosmetics</a></td>
      <td>Cosmetics ingredients come from a variety of sources but, unlike the ingredients of food, are often not considered by most consumers.  Cosmetics often use vibrant colors that are derived from a wide variety of sources, ranging from crushed insects to rust.Cosmetics in a variety of forms date back to early civilizations, with the need to improve ones personal appearance being an important factor in attracting a mate.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Lawsuit">Lawsuit</a></td>
      <td>A lawsuit is a proceeding by a party or parties against another in the civil court of law. The archaic term "suit in law" is found in only a small number of laws still in effect today.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Vexatious_litigation">Vexatious litigation</a></td>
      <td>Vexatious litigation is legal action which is brought  solely to harass or subdue an adversary. It may take the form of a primary frivolous lawsuit or may be the repetitive, burdensome, and unwarranted filing of meritless motions in a matter which is otherwise a meritorious cause of action.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Balance_sheet">Balance sheet</a></td>
      <td>In financial accounting, a balance sheet (also known as statement of financial position or statement of financial condition) is a summary of the financial balances of an individual or organization, whether it be a sole proprietorship, a business partnership, a corporation, private limited company or other organization such as government or not-for-profit entity. Assets, liabilities and ownership equity are listed as of a specific date, such as the end of its financial year.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Trustmark_(bank)">Trustmark (bank)</a></td>
      <td>Trustmark is a commercial bank and financial services company headquartered in Jackson, Mississippi, United States, with subsidiaries Trustmark National Bank, Trustmark Investment Advisors, and Fisher Brown Bottrell Insurance. The bank's initial predecessor, The Jackson Bank, was chartered by the State of Mississippi in 1889.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Form_10-K">Form 10-K</a></td>
      <td>A Form 10-K is an annual report required by the U.S. Securities and Exchange Commission (SEC), that gives a comprehensive summary of a company's financial performance. Although similarly named, the annual report on Form 10-K is distinct from the often glossy "annual report to shareholders," which a company must send to its shareholders when it holds an annual meeting to elect directors (though some companies combine the annual report and the 10-K into one document).</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Federal_takeover_of_Fannie_Mae_and_Freddie_Mac">Federal takeover of Fannie Mae and Freddie Mac</a></td>
      <td>In September 2008 the Federal Housing Finance Agency (FHFA) announced that it would take over the Federal National Mortgage Association (Fannie Mae) and the Federal Home Loan Mortgage Corporation (Freddie Mac). Both government-sponsored enterprises, which finance home mortgages in the United States by issuing bonds, had become illiquid as the market for those bonds collapsed in the subprime mortgage crisis.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Agile_management">Agile management</a></td>
      <td>Agile management is the application of the principles of Agile software development to various management processes, particularly project management. Following the appearance of the Manifesto for Agile Software Development in 2001, Agile techniques started to spread into other areas of activity.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Problem_management">Problem management</a></td>
      <td>Problem management is the process responsible for managing the lifecycle of all problems that happen or could happen in an IT service. The primary objectives of problem management are to prevent problems and resulting incidents from happening, to eliminate recurring incidents, and to minimize the impact of incidents that cannot be prevented.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Sport_management">Sport management</a></td>
      <td>Sport management is the field of business dealing with sports and recreation. Sports management involves any combination of skills that correspond with planning, organizing, directing, controlling, budgeting, leading, or evaluating of any organization or business within the sports field.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Women_Management">Women Management</a></td>
      <td>Women Management is a modeling agency based in New York. Founded by Paul Rowland in 1988,  Women also has two sister agencies, Supreme Management and Women 360 Management, which is also part of the Women International Agency Chain.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Test_management">Test management</a></td>
      <td>Test management most commonly refers to the activity of managing a testing process. A test management tool is software used to manage tests (automated or manual) that have been previously specified by a test procedure.</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='risk_factors'>Risk Factors</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>NUTRACEUTICAL INTERNATIONAL CORP      Item 1A                <font color="blue">Risk Factors</font></td>
    </tr>
    <tr>
      <td>Forward-Looking Statements and Certain Risks       The <font color="blue">statements contained</font> in this report that are not <font color="blue">purely historical</font> are     “forward-looking  statements” within the meaning of Section 21E of the     <font color="blue"><font color="blue">Securities </font>Exchange Act</font></td>
    </tr>
    <tr>
      <td>These statements regard our <font color="blue">expectations</font>, hopes,     beliefs, commitments, intentions, and strategies regarding the future</td>
    </tr>
    <tr>
      <td><font color="blue">They     </font>may  be  identified by the use of words or phrases, such as “believe,”     “expect,” “anticipate,” “should,” “plan,” “estimate,” and “potential,” among     others</td>
    </tr>
    <tr>
      <td>Forward-looking  statements  include, but are not limited to,     <font color="blue">statements contained</font> in “Business” and “Management’s Discussion and Analysis     of Financial Condition and Results of Operations” regarding our financial     performance, revenue and <font color="blue">expense levels</font> in the future, and the <font color="blue">sufficiency</font>     of our <font color="blue">existing assets</font> to <font color="blue">fund future <font color="blue">operations</font></font> and <font color="blue">capital spending</font> needs</td>
    </tr>
    <tr>
      <td>Actual results <font color="blue">could differ materially from</font> the anticipated results or other     <font color="blue">expectations</font>  expressed in these forward-looking statements or for the     <font color="blue">reasons discussed</font> below</td>
    </tr>
    <tr>
      <td>The fact that some of the <font color="blue">risk factors may</font> be the     same  or similar to past reports we have <font color="blue">filed with</font> the <font color="blue">Securities </font>and     Exchange  Commission means only that the risks are present in multiple     periods</td>
    </tr>
    <tr>
      <td>We believe that many of the <font color="blue">risks detailed</font> here are part of doing     business in the industry in which we operate and compete and <font color="blue">will likely</font> be     present in all periods reported</td>
    </tr>
    <tr>
      <td>The fact that <font color="blue">certain risks</font> are endemic to     the  industry  does not lessen their significance</td>
    </tr>
    <tr>
      <td>The forward-looking     <font color="blue">statements contained</font> in this report are made as of the date of this report,     and we assume <font color="blue">no obligation</font> to update them or to update the reasons why     actual results <font color="blue">could differ from</font> those projected in these forward-looking     statements</td>
    </tr>
    <tr>
      <td>Among others, risks and <font color="blue">uncertainties</font> that may affect our     business, <font color="blue">financial condition</font>, performance, development, and results of     <font color="blue">operations</font> include the following:       Regulatory, Product Liability and Insurance Risks       Our products are subject to <font color="blue">government</font> regulation, which <font color="blue">could limit</font> or     prevent the sale of our products</td>
    </tr>
    <tr>
      <td>The <font color="blue">manufacture</font>, packaging, labeling,     advertising, promotion, <font color="blue">distribution</font>, and sale of our products are subject     to <font color="blue">regulation by numerous national</font> and <font color="blue">local <font color="blue">government</font>al agencies</font> in the     <font color="blue"><font color="blue">United States</font> </font>and other countries</td>
    </tr>
    <tr>
      <td>The <font color="blue">primary <font color="blue">regulatory</font> bodies</font> in the     <font color="blue"><font color="blue">United States</font> </font>are the <font color="blue">FDA and FTC Failure </font>to <font color="blue">comply with</font> these <font color="blue">regulatory</font>     <font color="blue">requirements</font>  may result in various types of penalties or fines</td>
    </tr>
    <tr>
      <td><font color="blue">These     </font>include injunctions, product withdrawals, recalls, product seizures, fines,     and <font color="blue">criminal prosecutions</font></td>
    </tr>
    <tr>
      <td><font color="blue">Individual </font>states <font color="blue">also regulate nutritional</font>     <font color="blue">supplements</font></td>
    </tr>
    <tr>
      <td>A state <font color="blue">may interpret</font> claims or <font color="blue">products presumptively valid</font>     <font color="blue">under federal law as illegal under</font> that state’s <font color="blue">regulations</font></td>
    </tr>
    <tr>
      <td>In markets     outside the <font color="blue">United States</font>, we are usually required to obtain approvals,     licenses,  or  <font color="blue">certifications</font>  from  a country’s ministry of health or     comparable agency, as well as labeling and packaging <font color="blue">regulations</font>, all of     which  vary  from  country  to  country</td>
    </tr>
    <tr>
      <td><font color="blue">Approvals </font>or licensing may be     <font color="blue">conditioned</font> on <font color="blue">reformulation</font> of products or may be unavailable <font color="blue">with respect</font>     to  certain  products  or product <font color="blue">ingredients</font></td>
    </tr>
    <tr>
      <td>Any of these <font color="blue">government</font>     agencies, as well as <font color="blue">legislative</font> bodies, can change existing <font color="blue">regulations</font>, or     impose new ones, <font color="blue">which could</font> cause any of the following:       ·       <font color="blue">requirements</font> for the <font color="blue">reformulation</font> of certain or all products to     <font color="blue">meet new standards</font>,       ·       the recall or <font color="blue">discontinuance</font> of certain or all products,       ·       <font color="blue"><font color="blue">additional</font> record</font> keeping,       ·       expanded documentation of the properties of certain or all products,       13     ______________________________________________________________________       ·       expanded or <font color="blue">different labeling</font>,       ·       <font color="blue">adverse event tracking</font> and reporting, and       ·       <font color="blue"><font color="blue">additional</font> scientific substantiation</font></td>
    </tr>
    <tr>
      <td>Any or all of these <font color="blue">requirements</font> could have a material adverse effect on us</td>
    </tr>
    <tr>
      <td>There  can be no assurance that the <font color="blue">regulatory</font> environment in which we     operate will not change or that such <font color="blue">regulatory</font> environment, or any specific     action taken <font color="blue">against us</font>, will not result in a material adverse effect on us</td>
    </tr>
    <tr>
      <td>We may experience <font color="blue">product <font color="blue">liability</font></font> claims and <font color="blue">litigation</font> to <font color="blue">prosecute such</font>     claims, and although we maintain <font color="blue">product <font color="blue">liability</font></font> insurance, which we     believe to be adequate for our needs, there can be no assurance that our     <font color="blue">insurance coverage will</font> be adequate or that we will be able to maintain     <font color="blue">adequate insurance coverage</font></td>
    </tr>
    <tr>
      <td>As a <font color="blue"><font color="blue">manufacture</font>r</font> and a <font color="blue">distributor</font> of products     for <font color="blue">human consumption</font>, we experience <font color="blue">product <font color="blue">liability</font></font> claims and <font color="blue">litigation</font>     to <font color="blue">prosecute such</font> claims</td>
    </tr>
    <tr>
      <td>Additionally, the <font color="blue">manufacture</font> and sale of these     products involves the risk of injury to consumers as a result of tampering     by <font color="blue">unauthorized</font> third parties or product <font color="blue">contamination</font></td>
    </tr>
    <tr>
      <td>We carry insurance     coverage in the types and amounts that we consider <font color="blue"><font color="blue">reasonably</font> adequate</font> to     cover the risks we face</td>
    </tr>
    <tr>
      <td>Except for certain products that contain kava, our     current third-party <font color="blue">liability</font> policies exclude claims related to products     containing  ephedra or kava, as well as <font color="blue">additional</font> <font color="blue">ingredients</font></td>
    </tr>
    <tr>
      <td>We are     currently  party  to  <font color="blue">product <font color="blue">liability</font></font> lawsuits that <font color="blue">involve excluded</font>     <font color="blue">ingredients</font>, and there can be no assurance that we will not be subject to     <font color="blue">additional</font> lawsuits</td>
    </tr>
    <tr>
      <td>We have established a <font color="blue">captive insurance subsidiary</font> to     <font color="blue">provide coverage</font> for certain of our <font color="blue">product <font color="blue">liability</font></font> risks, including     excluded claims under our other policies</td>
    </tr>
    <tr>
      <td>We have accrued an <font color="blue">amount using</font>     the assistance of a third-party actuary that we believe is sufficient to     <font color="blue">cover probable</font> and <font color="blue"><font color="blue">reasonably</font> estimable liabilities</font> related to product     <font color="blue">liability</font>  claims  based  on  its history of such claims</td>
    </tr>
    <tr>
      <td>However, the     <font color="blue">capitalization</font> and income from premiums paid, both of which are <font color="blue">contributed</font>     by us, could be inadequate to cover a claim, <font color="blue">particularly</font> a material claim     that arises in the <font color="blue">first few years</font> of the captive’s <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>If insurance     coverage is inadequate or unavailable or <font color="blue">premium costs continue</font> to rise, we     may face <font color="blue">additional</font> claims not <font color="blue">covered by insurance</font>, and claims that exceed     <font color="blue">coverage limits</font> or that are not <font color="blue">covered could</font> have a material adverse effect     on us</td>
    </tr>
    <tr>
      <td>Market and Channel Risks       Our success is linked to the size and <font color="blue">growth rate</font> of the vitamin, mineral     and <font color="blue">supplement market</font> and an adverse change in the size or <font color="blue">growth rate</font> of     that <font color="blue">market could</font> have a material adverse effect on us</td>
    </tr>
    <tr>
      <td>Some <font color="blue"><font color="blue">manufacture</font>r</font>s     in  our  industry have experienced a slow-down in sales of nutritional     <font color="blue">supplements</font></td>
    </tr>
    <tr>
      <td>An adverse change in size or <font color="blue">growth rate</font> of the vitamin,     mineral and <font color="blue">supplement market</font> could have a material adverse effect on us</td>
    </tr>
    <tr>
      <td><font color="blue">Underlying  </font>market  <font color="blue">conditions</font> are subject to change <font color="blue">based on economic</font>     <font color="blue">conditions</font>, consumer preferences and other factors that are beyond our     control, including <font color="blue">media attention</font> and scientific research, which may be     positive or negative</td>
    </tr>
    <tr>
      <td>Because a substantial majority of our sales are to or <font color="blue">through health food</font>     stores, we are <font color="blue">dependent</font> to a large <font color="blue">degree upon</font> the success of this channel     as well as the success of <font color="blue">specific retailers</font> in the channel</td>
    </tr>
    <tr>
      <td>Over 90prca of our     sales are in the <font color="blue"><font color="blue">United States</font> </font>and Canada</td>
    </tr>
    <tr>
      <td>In those two markets, we sell our     <font color="blue">products primarily</font> to or <font color="blue">through health food</font> stores</td>
    </tr>
    <tr>
      <td>Because of this, we are     <font color="blue">dependent</font> to a large <font color="blue">degree upon</font> the success of that channel as well as the     success of <font color="blue">specific retailers</font> in the channel</td>
    </tr>
    <tr>
      <td>There are some large chains of     <font color="blue">health food stores</font>, such as Whole Foods, Wild Oats and Vitamin Shoppe, but     <font color="blue">most <font color="blue">health food stores</font></font> are individual stores or very small chains</td>
    </tr>
    <tr>
      <td>We rely     on these <font color="blue">health food stores</font> to purchase, market, and sell our products</td>
    </tr>
    <tr>
      <td>Our     success is <font color="blue">dependent</font>, to a large degree, on the growth and success of the     healthy  foods  channel, which is outside our control</td>
    </tr>
    <tr>
      <td>There can be no     assurance that the <font color="blue"><font color="blue">healthy foods</font> channel will</font> be able to grow or <font color="blue">prosper as</font>     it <font color="blue">faces price</font> and <font color="blue">service pressure from</font> other channels, including the mass     market</td>
    </tr>
    <tr>
      <td>There can be no assurance that retailers in the <font color="blue">healthy foods</font>     channel, in the aggregate, will respond or continue to respond to our stated     loyalty to this channel</td>
    </tr>
    <tr>
      <td>14     ______________________________________________________________________       We are highly <font color="blue">dependent</font> upon consumers’ <font color="blue">perception</font> of the safety and quality     of our <font color="blue">products as well as</font> similar <font color="blue">products distributed by</font> other companies     in  our industry, and <font color="blue">adverse publicity</font> and <font color="blue"><font color="blue">negative public</font> <font color="blue">perception</font></font>     regarding particular <font color="blue">ingredients</font> or products or our industry in general     <font color="blue">could limit</font> our ability to <font color="blue">increase revenue</font> and grow our business</td>
    </tr>
    <tr>
      <td><font color="blue">Decisions     </font>about  purchasing made <font color="blue">by consumers</font> of our products may be <font color="blue">affected by</font>     adverse  publicity  or <font color="blue"><font color="blue">negative public</font> <font color="blue">perception</font></font> regarding particular     <font color="blue">ingredients</font> or products or our industry in general</td>
    </tr>
    <tr>
      <td>This <font color="blue">negative public</font>     <font color="blue">perception</font>  may include publicity regarding the legality or quality of     particular <font color="blue">ingredients</font> or products in general or of other companies or our     products or <font color="blue">ingredients</font> specifically</td>
    </tr>
    <tr>
      <td>Negative public <font color="blue">perception</font> may also     arise  from  <font color="blue">regulatory</font>  <font color="blue">investigations</font>,  <font color="blue">regardless</font>  of whether those     <font color="blue">investigations</font>  involve  us</td>
    </tr>
    <tr>
      <td>We  are highly <font color="blue">dependent</font> upon consumers’     <font color="blue">perception</font> of the safety and quality of our <font color="blue">products as well as</font> similar     <font color="blue">products distributed by</font> other companies</td>
    </tr>
    <tr>
      <td>Thus, the mere <font color="blue">publication</font> of     reports asserting that such products may be harmful could have a material     adverse effect on us, <font color="blue">regardless</font> of whether these reports are <font color="blue">scientifically</font>     supported</td>
    </tr>
    <tr>
      <td><font color="blue">Publicity </font>related to nutritional <font color="blue">supplements</font> may also result in     increased <font color="blue">regulatory</font> scrutiny of our industry and/or the <font color="blue">healthy foods</font>     channel</td>
    </tr>
    <tr>
      <td><font color="blue">Adverse  </font><font color="blue">publicity may</font> have a material adverse effect on our     business, <font color="blue">financial condition</font>, and results of <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>There can be no     assurance of future favorable scientific results and <font color="blue">media attention</font> or of     the absence of unfavorable or <font color="blue">inconsistent findings</font></td>
    </tr>
    <tr>
      <td>We  face  intense  <font color="blue">competition</font>  <font color="blue">from <font color="blue">competitors</font></font> that are larger, more     established and that possess <font color="blue">greater resources than</font> we do, and if we are     unable to <font color="blue">compete <font color="blue">effectively</font></font>, we may be unable to maintain sufficient     market share to <font color="blue">sustain <font color="blue">profitability</font></font></td>
    </tr>
    <tr>
      <td>Numerous <font color="blue"><font color="blue">manufacture</font>r</font>s and retailers     <font color="blue">compete actively</font> for consumers</td>
    </tr>
    <tr>
      <td>There can be no assurance that we will be     able to compete in this <font color="blue">intensely competitive environment</font></td>
    </tr>
    <tr>
      <td>In addition,     nutritional <font color="blue">supplements</font> can be purchased in a wide variety of channels of     <font color="blue">distribution</font></td>
    </tr>
    <tr>
      <td>These channels include <font color="blue">mass market retail stores</font> and the     Internet</td>
    </tr>
    <tr>
      <td>Because these <font color="blue">markets generally</font> have <font color="blue">low barriers</font> to entry,     <font color="blue">additional</font> <font color="blue">competitors</font> could enter the <font color="blue">market at</font> any time</td>
    </tr>
    <tr>
      <td>Private label     products  of  our  customers also provide <font color="blue">competition</font> to our products</td>
    </tr>
    <tr>
      <td><font color="blue">Additional </font>national or international companies may seek in the future to     enter or to increase their presence in the <font color="blue">healthy foods</font> channel or the     vitamin, mineral <font color="blue">supplement market</font></td>
    </tr>
    <tr>
      <td><font color="blue">Increased </font><font color="blue">competition</font> in either or both     could have a material adverse effect on us</td>
    </tr>
    <tr>
      <td>The nutritional supplement industry increasingly relies on <font color="blue">intellectual</font>     <font color="blue">property rights</font> and although we seek to ensure that we do not infringe the     <font color="blue">intellectual</font> <font color="blue">property rights</font> of others, there can be no assurance that third     <font color="blue">parties will</font> not assert <font color="blue"><font color="blue">intellectual</font> <font color="blue">property <font color="blue">infringement</font></font></font> claims against     us, which claims may result in substantial costs and diversion of <font color="blue">management</font>     and  other  resources  and could have a material adverse effect on our     business,  financial  condition, and operating results</td>
    </tr>
    <tr>
      <td><font color="blue">Recently </font>it is     becoming more and more common for suppliers and <font color="blue">competitors</font> to apply for     patents or develop <font color="blue">proprietary technologies</font> and processes</td>
    </tr>
    <tr>
      <td>We seek to ensure     that we do not infringe the <font color="blue">intellectual</font> <font color="blue">property rights</font> of others, but     there can be no assurance that third <font color="blue">parties will</font> not assert <font color="blue">intellectual</font>     <font color="blue">property <font color="blue">infringement</font></font> claims <font color="blue">against us</font></td>
    </tr>
    <tr>
      <td>These <font color="blue">developments</font> can <font color="blue">prevent us</font>     from  offering or <font color="blue">supplying competitive products</font> or <font color="blue">ingredients</font> in the     marketplace</td>
    </tr>
    <tr>
      <td>They can also result in <font color="blue">litigation</font> or threatened <font color="blue">litigation</font>     <font color="blue">against us</font> related to alleged or <font color="blue">actual <font color="blue">infringement</font></font> of third-party rights</td>
    </tr>
    <tr>
      <td>If an <font color="blue">infringement</font> claim is asserted or <font color="blue">litigation</font> is pursued, we may be     required to obtain a license of rights, pay royalties on a <font color="blue">retrospective</font> or     prospective basis, or terminate our <font color="blue">manufacturing</font> and marketing of our     products that are alleged to have infringed</td>
    </tr>
    <tr>
      <td><font color="blue">Litigation </font><font color="blue">with respect</font> to such     matters can result in substantial costs and diversion of <font color="blue">management</font> and     other resources and could have a material adverse effect on our business,     <font color="blue">financial condition</font>, and operating results</td>
    </tr>
    <tr>
      <td>There can be no assurance that     third-party claims will not in the <font color="blue">future adversely affect</font> our business,     <font color="blue">financial condition</font>, and results of <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>Business Strategy and Operational Risks       If we are unable to retain <font color="blue">key personnel</font>, our ability to manage our business     <font color="blue">effectively</font>  and continue our <font color="blue">growth could</font> be <font color="blue"><font color="blue">negatively</font> impacted</font></td>
    </tr>
    <tr>
      <td>Key     <font color="blue">management</font> employees include Frank W Gay II, Bruce R       15     ______________________________________________________________________       Hough, Jeffrey A Hinrichs, Gary M Hume, Leslie M Brown, Jr, Stanley E     Soper,  Cory  J  McQueen,  Christopher B Neuberger and certain other     employees</td>
    </tr>
    <tr>
      <td>These key <font color="blue">management</font> employees are <font color="blue">primarily responsible</font> for our     day-to-day <font color="blue">operations</font>, and we believe our <font color="blue">success depends</font> in part on our     ability to retain them and to continue to attract <font color="blue">additional</font> qualified     <font color="blue">individuals</font> to our <font color="blue">management</font> team</td>
    </tr>
    <tr>
      <td>We do not have an <font color="blue">employment agreement</font>     with any of our key <font color="blue">management</font> employees</td>
    </tr>
    <tr>
      <td>The loss or <font color="blue">limitation</font> of the     services of any of our key <font color="blue">management</font> employees or the <font color="blue">inability</font> to attract     <font color="blue">additional</font> qualified <font color="blue">management</font> personnel could have a material adverse     effect on our business, <font color="blue">financial condition</font>, and results of <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>As a part of our business strategy, we have made and expect to continue to     make <font color="blue">acquisitions</font> that could disrupt our <font color="blue">operations</font> and harm our operating     results</td>
    </tr>
    <tr>
      <td>An  element  of  our strategy includes expanding our product     offerings, gaining shelf-space and <font color="blue">gaining access</font> to new skills and other     resources through strategic <font color="blue">acquisitions</font> when <font color="blue">attractive opportunities</font>     arise</td>
    </tr>
    <tr>
      <td><font color="blue">Acquiring </font><font color="blue">additional</font> <font color="blue">businesses</font> and the <font color="blue">implementation</font> of other     elements  of  our  business  strategy are subject to <font color="blue">various risks</font> and     <font color="blue">uncertainties</font></td>
    </tr>
    <tr>
      <td>These risks and <font color="blue">uncertainties</font> include, but are not     limited to, the following:       ·       Any <font color="blue">acquisition may</font> result in <font color="blue">significant expenditures</font> of cash,     stock and/or <font color="blue">management</font> resources,       ·       Acquired <font color="blue">businesses</font> may not perform in accordance with <font color="blue">expectations</font>,       ·       We <font color="blue">may encounter difficulties</font> and <font color="blue">costs with</font> the <font color="blue">integration</font> of the     acquired <font color="blue">businesses</font>,       ·       Management’s <font color="blue">attention may</font> be <font color="blue">diverted from</font> other aspects of our     business,       ·       We <font color="blue">may face unexpected problems entering geographic</font> and product     markets in which we have limited or <font color="blue">no direct prior</font> experience,       ·       We <font color="blue">may lose key employees</font> of acquired or existing <font color="blue">businesses</font>,       ·        We  may  <font color="blue">incur liabilities</font> and claims arising out of acquired     <font color="blue">businesses</font>,       ·       We may be unable to obtain financing, and       ·       We <font color="blue">may incur indebtedness</font> or issue <font color="blue">additional</font> capital stock which     could be dilutive to holders of our <font color="blue">common stock</font></td>
    </tr>
    <tr>
      <td>There can be no assurance that <font color="blue">attractive acquisition opportunities will</font> be     available to us, that we will be able to obtain financing for or otherwise     consummate any <font color="blue">acquisitions</font> or that any <font color="blue">acquisitions</font> which are consummated     will  prove  to  be  successful</td>
    </tr>
    <tr>
      <td>There can be no assurance that we can     <font color="blue">successfully</font> execute all aspects of our business strategy</td>
    </tr>
    <tr>
      <td>Because we <font color="blue">depend on outside suppliers with whom</font> we do not have long-term     <font color="blue">agreements</font> for <font color="blue">raw materials</font>, we may be unable to obtain <font color="blue">adequate supplies</font>     of <font color="blue">raw materials</font> for our <font color="blue">products at</font> favorable prices or at all, <font color="blue">which could</font>     result  in  <font color="blue">product shortages</font> and <font color="blue">back orders</font> for our products, with a     resulting loss of net sales and <font color="blue">profitability</font></td>
    </tr>
    <tr>
      <td>We acquire all of our raw     materials for the <font color="blue">manufacture</font> of our products from third-party suppliers</td>
    </tr>
    <tr>
      <td>We have few if     any <font color="blue">agreements</font> for the <font color="blue">continued supply</font> of these materials and products</td>
    </tr>
    <tr>
      <td>A     number of our <font color="blue">products contain one</font> or more <font color="blue">ingredients</font> that may only be     <font color="blue">available from</font> a <font color="blue">single source</font> or supplier</td>
    </tr>
    <tr>
      <td>Any of our suppliers could     <font color="blue">discontinue</font> selling to us at any time</td>
    </tr>
    <tr>
      <td>Although we believe that we could     establish  <font color="blue">alternate sources</font> for most of these materials, any delay in     locating and <font color="blue">establishing relationships with</font> other <font color="blue">sources could</font> result in     <font color="blue">product shortages</font> and <font color="blue">back orders</font> for the products, with a resulting loss of     net sales</td>
    </tr>
    <tr>
      <td>We are also subject to delays associated with <font color="blue">raw materials</font></td>
    </tr>
    <tr>
      <td>These can be caused by <font color="blue">conditions</font> not within our control, including:       ·       weather,       16     ______________________________________________________________________       ·       crop <font color="blue">conditions</font>,       ·       <font color="blue">transportation <font color="blue">interruption</font>s</font>,       ·       <font color="blue">strikes by supplier employees</font>, and       ·       <font color="blue">natural <font color="blue">disasters</font></font> or other <font color="blue">catastrophic events</font></td>
    </tr>
    <tr>
      <td>We acquire many <font color="blue">ingredients</font> from suppliers outside of the <font color="blue">United States</font></td>
    </tr>
    <tr>
      <td><font color="blue">Purchasing </font>these <font color="blue">ingredients</font> is subject to the <font color="blue">risks generally associated</font>     with importing <font color="blue">raw materials</font> from other countries, including, among other     factors, delays in shipments, changes in economic and political <font color="blue">conditions</font>,     quality  assurance,  tariffs,  trade  disputes  and  foreign  currency     <font color="blue">fluctuations</font></td>
    </tr>
    <tr>
      <td>These <font color="blue">factors could</font> result in a delay in or <font color="blue">disruption</font> of the     supply of certain <font color="blue">raw materials</font></td>
    </tr>
    <tr>
      <td>Any <font color="blue">significant delay</font> in or <font color="blue">disruption</font> of     the supply of <font color="blue">raw materials</font> could have a material adverse effect upon us</td>
    </tr>
    <tr>
      <td>Our success is <font color="blue">dependent</font> on the accuracy, re<font color="blue">liability</font>, and proper use of     <font color="blue">sophisticated</font> and dependable information <font color="blue">processing systems</font> and <font color="blue">management</font>     information <font color="blue">technology</font> and any <font color="blue">interruption</font> in these <font color="blue">systems could</font> have a     material adverse effect on our business, <font color="blue">financial condition</font>, and results of     <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>Our success is <font color="blue">dependent</font> on the accuracy, re<font color="blue">liability</font>, and     proper use of <font color="blue">sophisticated</font> and dependable information <font color="blue">processing systems</font>     and <font color="blue">management</font> information <font color="blue">technology</font></td>
    </tr>
    <tr>
      <td>Our information <font color="blue">technology</font> systems     are designed and selected in order to <font color="blue">facilitate</font> order entry and customer     billing, maintain customer records, accurately track purchases and incentive     payments, manage accounting, finance and <font color="blue">manufacturing</font> <font color="blue">operations</font>, generate     reports,  and  provide  customer  service  and  <font color="blue">technical support</font></td>
    </tr>
    <tr>
      <td>Any     <font color="blue">interruption</font> in these <font color="blue">systems could</font> have a material adverse effect on our     business, <font color="blue">financial condition</font>, and results of <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>Because we <font color="blue">manufacture</font> over 80prca of our products, we are <font color="blue">dependent</font> upon the     <font color="blue">uninterrupted</font> and <font color="blue"><font color="blue">efficient</font> operation</font> of our <font color="blue">manufacturing</font> <font color="blue">facilities</font>, which     are  subject to <font color="blue">power failures</font>, the <font color="blue">breakdown</font>, failure, or substandard     performance  of  equipment,  the <font color="blue">improper installation</font> or operation of     equipment, natural or other <font color="blue">disasters</font>, and the need to <font color="blue">comply with</font> the     <font color="blue">requirements</font> or <font color="blue">directives</font> of <font color="blue">government</font> agencies, including the <font color="blue">FDA We     </font><font color="blue">manufacture</font> over 80prca of our products</td>
    </tr>
    <tr>
      <td>As a result, we are <font color="blue">dependent</font> upon the     <font color="blue">uninterrupted</font> and <font color="blue"><font color="blue">efficient</font> operation</font> of our <font color="blue">manufacturing</font> <font color="blue">facilities</font> in     Ogden, Utah</td>
    </tr>
    <tr>
      <td>Those <font color="blue">operations</font> are subject to <font color="blue">power failures</font>, the <font color="blue">breakdown</font>,     failure, or <font color="blue">substandard performance</font> of equipment, the <font color="blue">improper installation</font>     or operation of equipment, natural or other <font color="blue">disasters</font>, and the need to     <font color="blue">comply with</font> the <font color="blue">requirements</font> or <font color="blue">directives</font> of <font color="blue">government</font> agencies, including     the FDA There can be no assurance that the occurrence of these or any other     <font color="blue">operational problems at</font> our <font color="blue">facility would</font> not have a material adverse     effect on our business, <font color="blue">financial condition</font>, and results of <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>We are party to a number of lawsuits that arise in the ordinary course of     business and <font color="blue">may become party</font> to others and while none of the lawsuits in     which we are <font color="blue">involved as</font> of the date of this filing are <font color="blue">reasonably</font> estimated     to be material, it is possible that future <font color="blue">litigation</font> could arise or that     <font color="blue">developments</font> could occur in existing <font color="blue">litigation</font> that could have material     <font color="blue">adverse effects on us</font></td>
    </tr>
    <tr>
      <td>We are party to a number of lawsuits that arise in     the  ordinary  course  of business and <font color="blue">may become party</font> to others</td>
    </tr>
    <tr>
      <td>The     <font color="blue">possibility</font> of such <font color="blue">litigation</font>, and its timing, is in large part outside our     control</td>
    </tr>
    <tr>
      <td>While none of the <font color="blue">current lawsuits</font> in which we are involved are     <font color="blue">reasonably</font> estimable to be material as of the date of this filing, it is     possible that future <font color="blue">litigation</font> could arise, or <font color="blue">developments</font> could occur in     existing <font color="blue">litigation</font>, that could have material <font color="blue">adverse effects on us</font></td>
    </tr>
    <tr>
      <td>If  we  fail  to maintain adequate and <font color="blue">effective internal control over</font>     financial  reporting,  our ability to manage our business, <font color="blue">comply with</font>     Sarbanes-Oxley, obtain required <font color="blue">auditor attestation</font> and <font color="blue">provide reliable</font>     financial reporting could be impaired and our <font color="blue">management</font> and <font color="blue">auditors may</font> be     precluded  from  <font color="blue">certifying</font>  <font color="blue">effective internal control over</font> financial     reporting, <font color="blue">which could</font> harm our business reputation and cause our stock     price to decline</td>
    </tr>
    <tr>
      <td>As <font color="blue">directed by</font> Section 404 of the Sarbanes-Oxley Act of     2002, the <font color="blue">Securities </font>and Exchange Commission <font color="blue">adopted rules</font> requiring public     companies to include a report of <font color="blue">management</font> on the       17     ______________________________________________________________________       company’s internal <font color="blue">control <font color="blue">over financial</font></font> reporting in their <font color="blue">Annual Reports     </font>on Form 10-K In addition, the in<font color="blue">dependent</font> registered public accounting firm     auditing a public company’s <font color="blue">financial statements</font> must attest to and report     on <font color="blue">management</font>’s <font color="blue">assessment</font> of the <font color="blue">effectiveness</font> of the company’s internal     <font color="blue">control <font color="blue">over financial</font></font> reporting</td>
    </tr>
    <tr>
      <td>Although our auditors did so attest in     <font color="blue">connection</font>  with this <font color="blue">Annual Report </font>on Form 10-K, if in the future our     in<font color="blue">dependent</font> registered public accounting firm is not <font color="blue">satisfied with</font> our     internal  <font color="blue">control <font color="blue">over financial</font></font> reporting or the <font color="blue">level at which</font> these     controls are documented, designed, operated or reviewed, or if that firm     interprets the <font color="blue">requirements</font>, rules or <font color="blue">regulations</font> differently from the way     we  interpret  them,  then  they may decline to attest to <font color="blue">management</font>’s     <font color="blue">assessment</font>  or  may  issue  a  report that is qualified or has a scope     <font color="blue">limitation</font></td>
    </tr>
    <tr>
      <td>From time-to-time, in our <font color="blue">ongoing effort</font> to improve business and     <font color="blue">operational processes</font> and our internal <font color="blue">control <font color="blue">over financial</font></font> reporting, we     or our <font color="blue">auditors may</font> determine that “<font color="blue">significant <font color="blue">deficiencies</font></font>” or “material     <font color="blue">weaknesses</font>”  (as  such  terms  are  <font color="blue">defined under accounting standards</font>     <font color="blue">established by</font> the Public Company Accounting Oversight Board) exist or that     our  internal  control  <font color="blue">over financial</font> reporting <font color="blue">may otherwise</font> require     <font color="blue">improvement</font></td>
    </tr>
    <tr>
      <td><font color="blue">Significant </font><font color="blue">deficiencies</font> or material <font color="blue">weaknesses</font> could impair     our ability to <font color="blue">provide <font color="blue">financial statements</font></font> that can be <font color="blue">relied upon</font></td>
    </tr>
    <tr>
      <td>If this     were to occur, our business <font color="blue">reputation could</font> be harmed and <font color="blue">investors may</font>     <font color="blue">lose confidence</font> in the re<font color="blue">liability</font> of our <font color="blue">financial statements</font> and reports,     either of <font color="blue">which could</font> have a <font color="blue">significant negative impact on</font> our stock price</td>
    </tr>
    <tr>
      <td>Stock Market Risks       The <font color="blue">market price</font> for our <font color="blue">common stock</font> may be <font color="blue">particularly</font> volatile, and our     <font color="blue">stockholders may</font> be unable to resell their shares at a profit</td>
    </tr>
    <tr>
      <td>The trading     price of our <font color="blue">common stock</font> has been subject to wide <font color="blue">fluctuations</font> and may     continue to fluctuate in the future in response to a variety of factors,     including:       ·       quarter-to-quarter variations in operating results,       ·       material <font color="blue">announcements</font> by us or our <font color="blue">competitors</font>,       ·       <font color="blue">government</font>al <font color="blue">regulatory</font> action,       ·       negative or positive <font color="blue">publicity involving us</font> or the nutritional     <font color="blue">supplement industry generally</font>,       ·       <font color="blue">general economic downturns</font>,       ·        <font color="blue">announcements</font>  by  official  or <font color="blue">unofficial health</font> and medical     <font color="blue">authorities</font>,       ·       <font color="blue">consumer preferences generally</font>, or       ·       other events or factors, many of which are beyond our control</td>
    </tr>
    <tr>
      <td>In addition, the <font color="blue">stock market</font> has <font color="blue">historically</font> experienced <font color="blue">significant price</font>     and volume <font color="blue">fluctuations</font>, which have <font color="blue">particularly</font> affected the <font color="blue">market price</font>s     of many <font color="blue">nutritional supplement companies</font> and which have, in <font color="blue">certain cases</font>,     not  had  a  strong  <font color="blue">correlation</font> to the operating performance of these     companies</td>
    </tr>
    <tr>
      <td>General economic <font color="blue">conditions</font>, such as recession or interest rate     or  currency  rate  <font color="blue">fluctuations</font> in the <font color="blue"><font color="blue">United States</font> </font>or abroad, could     <font color="blue">negatively</font> affect the <font color="blue">market price</font> of our <font color="blue">common stock</font></td>
    </tr>
    <tr>
      <td>In addition, our     operating  results in <font color="blue">future quarters may</font> be below the <font color="blue">expectations</font> of     <font color="blue">securities analysts</font> and investors</td>
    </tr>
    <tr>
      <td>In the past,     following  periods  of  <font color="blue">volatility</font>  in the <font color="blue">market price</font> of a company’s     securities, securities class action <font color="blue">litigation</font> has <font color="blue">often been instituted</font>     against that company</td>
    </tr>
    <tr>
      <td>Such <font color="blue">litigation</font> could result in substantial cost and a     diversion of <font color="blue">management</font>’s attention and resources</td>
    </tr>
  </tbody>
</table>